Chungbuk National University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Effects of dose modifications on the safety and efficacy of dacomitinib for mutation-positive non-small-cell lung cancer

    Future Oncology, Vol. 15, Núm. 24, pp. 2795-2805